|
67
|
276
|
5hyjA |
1e6 tcr in complex with hla-a02 carrying aqwgpdpaaa |
|
48
|
246
|
5hyjE |
1e6 tcr in complex with hla-a02 carrying aqwgpdpaaa |
|
38
|
214
|
5hysG |
Structure of ige complexed with omalizumab |
|
27
|
205
|
5hy9B |
Glycosylated, disulfide-linked knob-into-hole fc fragment |
|
21
|
105
|
5hsfA |
1.52 angstrom crystal structure of fc fragment of human igg1. |
|
76
|
274
|
5hhpA |
Crystal structure of hla-a*0201 in complex with m1-g4e |
|
12
|
100
|
5hghB |
Hla*a2402 complexed with hiv nef138 10mer epitope |
|
14
|
99
|
5hhqB |
Crystal structure of hla-a*0201 in complex with m1-l3w |
|
70
|
274
|
5hgbA |
Hla*a2402 complexed with hiv nef138 8mer epitope |
|
80
|
274
|
5hhqA |
Crystal structure of hla-a*0201 in complex with m1-l3w |
|
14
|
100
|
5hhoB |
Crystal structure of the jm22 tcr in complex with hla-a*0201 in complex with m1-g4e |
|
69
|
274
|
5gsxA |
Mouse mhc class i h-2kd with a mers-cov-derived peptide 142-2 |
|
14
|
99
|
5grgB |
Crystal structure of dual peptide from ebv in complex with hla-a*11:01 |
|
71
|
274
|
5gsbA |
Mouse mhc class i h-2kd with a mers-cov-derived peptide 37-3 |
|
73
|
274
|
5fdwA |
Structure of hla-a2:01 with peptide y10l |
|
12
|
98
|
5ad0B |
Complex of a b21 chicken mhc class i molecule and a 11mer chicken peptide |
|
40
|
204
|
7fabL |
Crystal structure of human immunoglobulin fragment fab new refined at 2.0 angstroms resolution |
|
68
|
274
|
6gl1A |
Hla-e*01:03 in complex with the hiv epitope, rl9hiv |
|
14
|
100
|
6gh4B |
Hla-e*01:03 in complex with the mtb44 peptide variant: mtb44*p2-gln. |
|
65
|
274
|
6ghnA |
Hla-e*01:03 in complex with the mtb44 peptide variant: mtb44*p9-phe. |
|
15
|
100
|
6gl1B |
Hla-e*01:03 in complex with the hiv epitope, rl9hiv |
|
13
|
100
|
6ghnB |
Hla-e*01:03 in complex with the mtb44 peptide variant: mtb44*p9-phe. |
|
73
|
274
|
6gh4A |
Hla-e*01:03 in complex with the mtb44 peptide variant: mtb44*p2-gln. |
|
72
|
274
|
6ggmA |
Hla-e*01:03 in complex with the mtb44 peptide variant: mtb44*p2-phe. |
|
15
|
100
|
6ggmB |
Hla-e*01:03 in complex with the mtb44 peptide variant: mtb44*p2-phe. |
|
35
|
216
|
6fczH |
Model of gc1q-fc complex based on 7a em map |
|
59
|
265
|
6fgbA |
Human fcrn extra-cellular domain complexed with fab fragment of rozanolixizumab |
|
14
|
99
|
6fgbB |
Human fcrn extra-cellular domain complexed with fab fragment of rozanolixizumab |
|
43
|
209
|
6fgoA |
Fc in complex with engineered calcium binding domain z |
|
56
|
214
|
6fabL |
Three-dimensional structure of murine anti-p-azophenylarsonate fab 36-71. 1. x-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten |
|
40
|
381
|
6enyC |
Structure of the human plc editing module |
|
8
|
99
|
6enyB |
Structure of the human plc editing module |
|
52
|
274
|
6enyF |
Structure of the human plc editing module |
|
78
|
275
|
6ei2A |
Crystal structure of hla-a68 presenting a c-terminally extended peptide |
|
27
|
232
|
6de7H |
Crystal structure at 4.3 a resolution of glycosylated hiv-1 clade a bg505 sosip.664 prefusion env trimer with interdomain stabilization 113c-429gcg in complex with broadly neutralizing antibodies pgt122 and 35o22 |
|
39
|
226
|
6dcvB |
Crystal structure of human anti-tau antibody cbtau-27.1 |
|
24
|
229
|
6de7D |
Crystal structure at 4.3 a resolution of glycosylated hiv-1 clade a bg505 sosip.664 prefusion env trimer with interdomain stabilization 113c-429gcg in complex with broadly neutralizing antibodies pgt122 and 35o22 |
|
31
|
208
|
6de7L |
Crystal structure at 4.3 a resolution of glycosylated hiv-1 clade a bg505 sosip.664 prefusion env trimer with interdomain stabilization 113c-429gcg in complex with broadly neutralizing antibodies pgt122 and 35o22 |
|
49
|
219
|
6dcwL |
Crystal structure of human anti-tau antibody cbtau-27.1 fab in complex with a human tau peptide |
|
53
|
220
|
6dcvA |
Crystal structure of human anti-tau antibody cbtau-27.1 |
|
37
|
223
|
6dcwH |
Crystal structure of human anti-tau antibody cbtau-27.1 fab in complex with a human tau peptide |
|
76
|
276
|
6d2tA |
Hla-b*57:01 presenting lalltgvrw |
|
15
|
100
|
6d2bB |
Hla-b*57:01 presenting lsdstardvtw |
|
14
|
100
|
6d2rB |
Hla-b*57:01 presenting gsfdysgvhlw |
|
74
|
276
|
6d29A |
Hla-b*57:01 presenting tsmsfvprpw |
|
15
|
100
|
6d29B |
Hla-b*57:01 presenting tsmsfvprpw |
|
77
|
276
|
6d2bA |
Hla-b*57:01 presenting lsdstardvtw |
|
78
|
276
|
6d2rA |
Hla-b*57:01 presenting gsfdysgvhlw |
|
14
|
100
|
6d2tB |
Hla-b*57:01 presenting lalltgvrw |
|
34
|
179
|
6cqrA |
Crystal structure of f24 tcr -dr1-rq13 peptide complex |
